Gastric ulcers (GUs) are common pathologies that affect many people around the world. Excessive alcohol consumption is one of the main causes of GUs; however, there are still lack of effective drugs for the prevention or therapy of GUs. In this study, we evaluated the protective effects and possible mechanisms of kaempferol (KAE) against acute ethanol-induced lesions to the gastric mucosa in mice. Fasted mice were orally given vehicle (0.9% saline), omeprazole (20 mg/kg), or KAE (40, 80, or 160 mg/kg) for 1 h in different experimental sets prior to the establishment of the GU model by challenge with absolute ethanol (10 ml/kg). Animals were euthanized 1 h after ethanol intake, and their plasma and stomach tissues were subject to further examination. Macroscopic and microscopic lesions, and immunological and biochemical parameters were observed. The effects of inflammation were investigated using the following indicators: tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), IL-6, myeloperoxidase (MPO), and nitric oxide (NO). Results showed that KAE significantly decreased the ulcer index, increased the preventive index, completely protected the mucosa from lesions, and preserved gastric mucosal glycoprotein. KAE decreased MPO activity and pro-inflammatory cytokine (TNF-α, and IL-1β) levels, and improved NO levels. The gastroprotective activity of KAE might be attributed to the preservation of gastric mucous glycoproteins levels, thus by inhibiting neutrophil accumulation and MPO activity, adjusting the levels of pro-inflammatory cytokines, and improving NO production.
Introduction
Gastric ulcers (GUs) are one of the most common diseases that affect humans in general and young people in particular [1, 2] . Acute GUs occur frequently as a result of alcohol consumption, ingestion of non-steroidal anti-inflammatory drugs (NSAIDs), and major stressful events such as shock, severe burns, trauma, and surgery [1, 3] . They may contribute to severe upper gastrointestinal bleeding with high mortality and morbidity [4] . The development of GUs is a complex and multi-factorial process, occurring from an imbalance between aggressive and protective factors present in the gastric mucosa [2, 5] . Some causes of GUs include the presence of Helicobacter pylori, decreased blood flow, increased acid secretion and pepsin activity, imbalanced bile salt secretion, and reduced mucus and bicarbonate secretion [6] . The crucial defense factors of the gastric mucosa include the secretion of bicarbonate and maintaining adequate levels of nitric oxide (NO) [7] .
Ethanol is a well-known damaging agent to the gastric mucosa, and excessive ethanol ingestion, serving as the main inducer of GUs in humans, causes acute gastric mucosal damage [8, 9] . Ethanol exposure results in a rush of activated neutrophil infiltration into the site of injury, leading to the damage of the gastric mucosa by increasing the production of pro-oxidative and proinflammatory enzymes and free radicals, resulting in oxidative stress [10] . Several studies have shown that pro-inflammatory cytokines such as tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), and IL-6 play important roles in the regulation of acute GUs induced by ethanol [11] [12] [13] . In addition, ethanol effectively reduces the level of NO needed for physiological functioning [7] in the gastric mucosa and slows the flow of gastric blood, thereby causing the development of hemorrhagic lesions and consequently leading to the solubilization of gastric mucus constituents [14] .
In classical studies, ethanol-induced GU animal models are often used to screen for compounds that possess anti-ulcer activity. There are several drug classes that have been used in the treatment of GUs, including proton pump inhibitors, M 1 -receptor blockers, and H 2 -receptor antagonists. However, there are many side effects associated with these drugs, including erectile dysfunction, arrhythmia, gynecomastia, and hematopoietic changes [15] . Therefore, there is a need to find new drugs that have fewer side effects than those currently used.
The flavonoid kaempferol (3,5,7,4'-tetrahydroxy flavone) is a yellow compound with a low molecular weight that is commonly found in many edible plants (e.g. tea, broccoli, cabbages, kale, beans, endives, leeks, tomatoes, strawberries, and grapes) and in botanical products commonly used in traditional medicine (e.g. Ginkgo biloba, Tilia spp., Equisetum spp., Moringa oleifera, Sophora japonica, and propolis) [16] . Several studies have shown that kaempferol (KAE) and some glycosides of KAE have a wide range of pharmacological activities, including antioxidant, antiinflammatory, antimicrobial, anticancer, cardioprotective, neuroprotective, anti-diabetic, and anxiolytic [16] . Further studies have indicated that KAE can suppress the production of TNF-α, IL-1β, and IL-6 [17] [18] [19] , down-regulate inducible NO synthase (iNOS) [16, 17] , and have cytoprotective effects and anti-apoptotic activities [19, 20] . Although, KAE glycoside therapy against ethanolinduced GUs in rats via anti-oxidant effects has been investigated [21] , its anti-inflammatory effects on GUs in mice have not been previously explored. Therefore, in the present study, we investigated the gastroprotective effects of KAE against ethanol-induced GUs in mice and the mechanism by which KAE exerts its effects in terms of inflammatory cytokine production and NO response.
Materials and Methods

Animals
Institute of Cancer Research mice weighing 25-35 g were purchased from the Experimental Animal Center, Zhejiang Academy of Medical Sciences (Hangzhou, China) and kept in cages of 10 animals each, with food and water ad libitum, in a controlled temperature room (24 ± 2°C) with a 12 h light/dark cycle and with relative humidity ranging from 60% to 70%. The mice were maintained and used in accordance with the guidelines of the Care and Use of Laboratory Animals, published by the US National Institute of Health.
Drugs and reagents
KAE, yellow powder (purity ≥ 98%), was purchased from Chengdu Must Bio-Technology Co., Ltd. (Chengdu, China). Omeprazole was obtained from China National Pharmaceutical Industry Corporation Ltd. (Beijing, China). The enzyme-linked immunosorbent assay (ELISA) kits for mouse TNF-α, IL-1β, and IL-6 were purchased from MultiSciences Biotech Co., Ltd (Hangzhou, China). The kits for NO, myeloperoxidase (MPO), and periodic acid-Schiff (PAS) staining were supplied by Nanjing Jiancheng Bioengineering Institute (Nanjing, China). Other reagents were of commercially available analytical grade. In this study, KAE and omeprazole were dissolved in 10% dimethyl sulfoxide (DMSO) as a drug vehicle.
Experimental protocol and establishment of an ethanol-induced gastric lesions model
After a 1-week adaptation period to the environment, mice were randomly divided into six experimental groups, each containing 10 animals: (i) group control: mice in this group received 10% DMSO (10 ml/kg) 1 h before being administered with 0.9% saline, (ii) group ethanol: mice in this group received 10% DMSO (10 ml/kg) 1 h before induction of ulcers with absolute ethanol, (iii) group omeprazole: mice in this group received omeprazole (20 mg/kg) 1 h before induction of ulcers, and (iv) groups KAE 40-160 : mice in these groups received KAE (40, 80, or 160 mg/kg, respectively) 1 h before induction of ulcers.
Prior to the experiment, mice were fasted for 12 h but with free access to water. Then mice were treated as above and administered intragastrically with absolute ethanol (10 ml/kg body weight) to induce acute ulcers while the control group received vehicle only. One hour after induction of ulcers, blood samples were collected from the retro-orbital plexus of each animal under pentobarbital anesthesia and were then centrifuged for 10 min at 4000 g to obtain clean plasma, which was stored at −20°C before use. Mice were then euthanized by cervical dislocation under pentobarbital anesthesia.
The GU index and preventive index
After the animals were sacrificed, the stomachs were removed quickly and washed with 0.9% physiological saline to clean away the blood. The degree of gastric mucosal lesions was evaluated from digital pictures, and the severity of mucosal lesions was scored as follows: no ulcer (0 mm), 1-5 petechiae (<1 mm) (1), 6-10 petechiae (<1 mm) (2), >10 petechiae (<1 mm) (3), small linear ulcer (<2 mm) (2), medium linear ulcer (2-4 mm) (3), and large linear ulcer (>4 mm) (4) . If the width was >1 mm, then the points were multiplied by two. The GU index (UI) was determined by adding the sum of the total of the scores and divided by the number of animals. This method of evaluation was adapted from a previous study [22] with slight modification. The preventive index (PI) of pretreatments against ulceration was calculated according to the following equation [23] : PI = (UI ethanol − UI pretreated ) / UI ethanol × 100.
Assay of MPO in the plasma
MPO activity was determined using an MPO activity measurement kit. In brief, 100 μl of plasma sample was homogenized in 50 mM potassium phosphate buffer, pH 6.0, containing 0.5% hexadecyltrimethyl ammonium bromide. Suspensions were centrifuged at 6000 g for 10 min at 4°C. The resulting supernatant was then collected and 100 μl of 0.3 mM H 2 O 2 was added. The color reaction was measured at 460 nm at room temperature with a spectrophotometer [24] . MPO activities were expressed as U/l.
Measurement of plasma TNF-α, IL-1β, and IL-6
The levels of cytokines (TNF-α, IL-1β, and IL-6) in plasma were measured using ELISA kits according to the manufacturer's instructions. Briefly, 100 μl of sample or cytokine standard was added to each well, and then 50 μl of diluted detection antibody was added. After 100 μl of diluted streptavidin-HRP and the substrate were added, the absorbance were measured at 450 and 630 nm. Then, the levels of IL-1β, TNF-α, and IL-6 were calculated by standard curves that were acquired according to the instructions. The results were expressed as pg/ml plasma.
Measurement of NO levels in plasma
The content of NO in the plasma was measured by the method of nitric acid reductase according to instructions of NO kit. Briefly, 50 μl of plasma sample was added to 50 μl Griess reagent [N-(1-naphthyl)-ethylene diamine dihydrochloride (0.1%), 1% sulfanilamide and 2.5% H 3 PO 4 ] and mixed. After incubation at 37°C for 60 min, the nitrite levels were determined spectrophotometrically at 550 nm [25] . The results were expressed as μM.
Histopathological examination of gastric mucosa
The gastric tissue specimens from the mice were fixed with 10% buffered formalin solution. Formalin-fixed stomach sections were embedded in paraffin wax. Then, the gastric samples were sectioned at a thickness of 5 μm and stained with hematoxylin and eosin (HE). Pathological observations were performed with a light microscope.
Mucosal glycoprotein detection
Mucosa glycoprotein measurement was performed using PAS staining kit according to the manufacturer's instructions. The gastric tissue specimens from the mice were sectioned and placed on slide and then deparaffinized, rehydrated, oxidized (0.5% periodic acid for 5 min), and washed with distilled water. Then slides were stained with Schiff's reagent for 30 min, followed by washing with sulfurous water (2 min for three times) and tap water (10 min). Then slides were counterstained with hematoxylin for 20 s, dehydrated, and finally examined under a light microscope.
Statistical analysis
All data are presented as the mean ± standard deviation (SD). Statistical software SPSS 18.0 (SPSS, Chicago, USA) was utilized. The results were statistically analyzed using a one-way analysis of variance (ANOVA) test. P < 0.05 were considered as significant difference.
Results
Macroscopic lesions of stomach and GU index
As shown in Fig. 1 , the animals that received absolute ethanol (10 ml/kg) had severe lesions with extensive visible hemorrhagic necrosis of gastric mucosa. This was attenuated by the preadministration of omeprazole (20 mg/kg) with a few fields of hyperemia. Furthermore, absolute ethanol-induced mucosal lesions were remarkably reduced in terms of size and severity among the mice that were pre-treated with KAE. The inhibition of hemorrhagic mucosal lesions in the KAE 40-160 groups was remarkable in comparison with the ethanol group. Fig. 2 shows that UI was significantly reduced in animals pretreated with both omeprazole and KAE (40, 80, and 160 mg/kg) (P < 0.001, P < 0.01, P < 0.001, and Figure 1 . Effect of KAE on the macroscopic morphology in ethanol-induced GU mice Control: control group. Ethanol: ethanol group. Omeprazole: omeprazole (20 mg/kg) group. KAE 40 : kaempferol (40 mg/kg) group. KAE 80 : kaempferol (80 mg/kg) group. KAE 160 : kaempferol (160 mg/kg) group. P < 0.001, respectively) when compared with the ethanol group. And the PI of pretreatment of ethanol-introduced mice with both omeprazole and KAE (40, 80, and 160 mg/kg) was 49%, 37%, 48%, and 67%, respectively.
Effect of KAE on MPO levels in plasma
We evaluated the activity of MPO in the plasma, and the results are shown in Fig. 3 . Treatment of mice with ethanol significantly increased the levels of plasma MPO by 49% (P < 0.001) as compared with the control group. Compared with the ethanol group, MPO levels were significantly decreased in the experimental groups at doses of 80 and 160 mg/kg KAE by 24% and 32%, respectively (P < 0.01 and P < 0.001). Similarly, the omeprazole group also showed a marked decrease in MPO content by 27% (P < 0.01).
Effect of KAE on plasma TNF-α and IL-1β concentrations
The results of the inflammatory cytokine analysis are shown in Fig. 4 . Treatment of mice with ethanol significantly increased the levels of plasma TNF-α and IL-1β by 44% and 40%, respectively (P < 0.001 and P < 0.05), as compared with the control group. Pretreatment of ethanol-introduced mice with both omeprazole and KAE (40, 80, and 160 mg/kg) caused a notable decrease in plasma TNF-α by 26%, 33%, 43%, and 48%, respectively (P < 0.01, P < 0.01, P < 0.001, and P < 0.001), and IL-1β by 28%, 46%, 43%, and 37%, respectively (P < 0.05, P < 0.001, P < 0.001, and P < 0.01), as compared with the ethanol group. Unexpectedly, IL-6 in the ethanol group exhibited a potent reduction by 72% (65 pg/ml, P < 0.05) when compared with the control group (232.8 pg/ml). The levels of IL-6 were effectively normalized in the omeprazole and KAE groups (160 mg/kg), which showed a significant increase by 103% and 432%, respectively (P < 0.05 and P < 0.05) relative to the ethanol group (data not shown).
Effect of KAE on NO in plasma
We analyzed the levels of NO in plasma, and the results are shown in Fig. 5 . The mice pretreated with KAE (40 mg/kg, 80 mg/kg, and 160 mg/kg) before ethanol administration showed an obvious increase in the level of NO by 31%, 41%, and 43%, respectively (P < 0.001, P < 0.001, and P < 0.001), when compared with the ethanol group. Similarly, the level of NO was also remarkably increased in the omeprazole group by 40% (P < 0.001).
Histological evaluation of the KAE effect on gastric mucosa
Histological examination was performed to evaluate the effect of KAE on gastric mucosa. As shown in Fig. 6 , the results of HE staining showed that pretreatment of KAE (160 mg/kg) alleviated the ethanolinduced pathological changes in the stomach, which ameliorated the edema, the leukocyte infiltration to the submucosal layer, and the destruction of the gastric epithelium in a dose-dependent manner. In contrast to what was found in the control group, the ethanol group showed a high degree of epithelial cell loss and inflammation as well as hemorrhagic patch formation on the gastric tissue. Omeprazole (20 mg/kg) resulted in comparatively better protection of the gastric mucosa as seen by reductions in the ulcer area and reduced or the absence of submucosal edema and epithelial cell loss. As shown in Fig. 7 , gastric mucosal glycoproteins were markedly decreased in the ethanol group, but pre-treatment with KAE (160 mg/kg) protect them to the greatest extent on the whole.
Discussion
In the present study, we successfully established a stable GU mouse model using ethanol to explore the gastroprotective properties of KAE and the underlying mechanisms. Our results demonstrated that pretreatment with KAE can notably reduce gastric lesions and histological damage in a dose-dependent manner, comparable to pretreatment with omeprazole, a proton pump inhibitor. As a positive control in this study, omeprazole has been widely used for the Figure 2 . Effect of KAE on gross lesions in ethanol-induced GU mice Data are presented as the mean ± SD from 10 animals per group.
### P < 0.001, compared with the control group; ***P < 0.001 and **P < 0.01 compared with the ethanol group. Figure 3 . Effect of KAE on MPO levels in plasma of ethanol-induced GU mice Each value represents the mean ± SD of 10 animals. ### P < 0.001, compared with the control group; ***P < 0.001 and **P < 0.01 compared with the ethanol group.
treatment of GUs and has been used in numerous published studies to provide a gastroprotective effect [6, 23, 26] . Furthermore, MPO activity and the levels of TNF-α and IL-1β in the plasma were decreased by KAE treatment, and the accumulation of gastric mucosal glycoprotein and the production of NO were obviously increased when compared with the ethanol group. Thus, the therapeutic effect of KAE on the ethanol-induced GUs may be associated with two components: inhibiting inflammation and protecting gastric mucosa. The results in this study showed that the activation and infiltration of neutrophils initiate the formation of lesions in the stomach. Similarly, a previous study reported that the reduction of neutrophil infiltration into ulcerated gastric tissue enhances the prevention of GUs in rats [27] . Since neutrophils contain large amounts of the hemoprotein MPO, the accumulation of neutrophils in gastric mucosal tissues can be measured by its activity [28] . In the present study, KAE at 160 mg/kg was found to protect the histological structure of the gastric mucosa, preventing swelling (Fig. 7) and the infiltration of inflammatory cells (neutrophils). Compared with the ethanol group, KAE showed significant inhibition of MPO accumulation, indicating that KAE may exert its therapeutic effects on GU by attenuating gastric mucosal inflammation.
Ethanol-induced GUs in mice have an inflammatory response associated with increased neutrophil infiltration that disturbs the inflammatory/anti-inflammatory cytokine balance [29] . Compared with the ethanol group, pre-administration of KAE obviously inhibited the production of inflammatory mediators (TNF-α, and IL-1β) in ethanol-induced GUs, suggesting that KAE possesses gastroprotective properties through reducing gastric mucosal inflammation. The results of this study provide direct evidence that KAE has a marked anti-inflammatory effect, which is consistent with previous studies [17, 18] . Interestingly, we found that ethanol administration decreased IL-6 level in plasma, which is different from other studies [9, 26] . The reason of this discrepancy might be the different protocols of ulcer induction employed in these studies. A previous study has indicated that lack of IL-6 leads to more severe ulceration in a mouse model of acetic acid-induced GUs, suggesting that low IL-6 level may play a role in ethanol-induced gastric injuries [30] .
It is well known that NO, namely endothelium-derived relaxing factor, causes vasodilatation of submucosal arterioles and increase in the mucosal blood flow. This increase in blood flow allows the buffering of acid that has entered the lamina propria and helps to dilute and remove any toxins that have crossed the epithelium [31] . Thus, the increased level of NO produced by constitutive NO synthase (cNOS) plays an important role in gastric protection through the dilation of gastric blood vessels, resulting in an increased supply of nutrients that contributes to the multiplication of cells that constitute the granulation tissue. This, consequently, contributes to the healing process of the gastric mucosa. Thus, we also detected the level of NO in the plasma of mice and found that pretreatment with KAE increased the level of NO when compared with the ethanol group, indicating that increased NO level is probably involved in the antiulcer effects of KAE by strengthening cNOS activity.
Future studies should be carried out to address the level of NO and the expression of cNOS and inducible NO synthase (iNOS) in the gastric tissue to clarify the molecular mechanism of NO production during the processing of GUs. Since the induction of highoutput iNOS usually occurs in an oxidative environment, high level of NO will react with superoxide anions, leading to peroxynitrite formation and cell toxicity, hydroxyl radical production, and tissue damage. It has been confirmed that high expression and activity of iNOS coincide with severe inflammation in ulcer tissues [32] . In addition, we should also focus on the advantages of using KAE in doses of 40 mg/kg, 80 mg/kg, and 160 mg/kg that it is easy to obtain from many edible plants or traditional herbs, and is safe for the GUsusceptible population without the side effects of clinical drugs currently used for GU therapy [16, 33] . Histological assessment of the effects of KAE on acute gastric mucosal injuries in ethanol-induced mice The gastric tissue (n = 6/group) was fixed with 4% paraformaldehyde and sectioned for PAS staining (magnification ×100). The carmine color in the apical epithelial cells represents PAS-positive staining. The black arrows showed no fuchsia in the base of mucosa. Figure 6 . Histological assessment of the effects of KAE on acute gastric mucosal injuries in ethanol-induced mice The gastric tissue (n = 6/group) was fixed with 4% paraformaldehyde and sectioned for HE staining (magnification ×100). The black arrow showed broad erosion in the upper half of mucosa.
In conclusion, we demonstrated that KAE exhibits antiulcerogenic activity and likely prevents ethanol-induced GUs by inhibiting neutrophil infiltration, reducing inflammatory cytokine (TNF-α and IL-1β) formation, enhancing gastric mucosa, and up-regulating IL-6 and NO.
